Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Sancy Bhd's average EBITDA Per Share Growth Rate was 200.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 108.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 47.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sancy Bhd was 108.00% per year. The lowest was 14.50% per year. And the median was 58.70% per year.
Sancy Bhd (XKLS:03057) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Sancy Bhd 5-Year EBITDA Growth Rate Related Terms
XKLS:03057 vs IBM, ACN, FISV: 5-Year EBITDA Growth Rate Comparison
For the Information Technology Services subindustry, Sancy Bhd's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sancy Bhd 5-Year EBITDA Growth Rate vs Software Industry
For the Software industry and Technology sector, Sancy Bhd's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Sancy Bhd's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 47.40% mean?
Sancy Bhd (XKLS:03057) has a 5-Year EBITDA Growth Rate of 47.40% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Sancy Bhd and its competitors.
Is Sancy Bhd's 5-Year EBITDA Growth Rate too high?
Sancy Bhd's current 5-Year EBITDA Growth Rate is 47.40%. Overall, Sancy Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Sancy Bhd's 5-Year EBITDA Growth Rate compare to IBM and ACN?
Sancy Bhd's 5-Year EBITDA Growth Rate of 47.40% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Software company?
A good 5-Year EBITDA Growth Rate depends on the Software industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Sancy Bhd and its competitors. Sancy Bhd's current 5-Year EBITDA Growth Rate is 47.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sancy Bhd stock overvalued right now?
Sancy Bhd (XKLS:03057) has a current 5-Year EBITDA Growth Rate of 47.40%. The stock's GF Value™ is RM0.41, compared to a current price of RM0.32 — trading 22% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 47.40%. Sancy Bhd's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Sancy Bhd (XKLS:03057), the current 5-Year EBITDA Growth Rate is 47.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sancy Bhd (XKLS:03057) Overvalued in 2026?
Based on GuruFocus' analysis, Sancy Bhd stock appears to be undervalued.
The current stock price of RM0.32 is trading 22% below its estimated GF Value™ of RM0.41.
Key valuation signals for XKLS:03057:
5-Year EBITDA Growth Rate: 47.40%
GF Value™: RM0.41 vs. price of RM0.32 (22% below fair value)
No single metric tells the full story. See the XKLS:03057 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sancy Bhd focuses on improving efficiency and value for healthcare service providers through digitalization. It is principally engaged in the business of investment holding and provision of digital healthcare solutions, other non-clinical information management systems, and related services. The group predominantly operates in one geographical area, which is Malaysia.
63GF Score
Get the complete analysis for XKLS:03057
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:03057 has been successfully added to your 
